EFEMP1 and metabolic dysfunction-associated steatotic liver disease: Although EFEMP1 is expressed in all organs of the body, serum Fibulin-3 in patients with MASLD is higher in cases with advanced liver fibrosis (Figure 2A) and high intrahepatic inflammation (Figure 2C), and there was a correlation between serum Fibulin-3 and intrahepatic Fibulin-3 expression (Supplemental Figure S2D, http://links.lww.com/HC9/A893) in our study.